ALTTO-open-paren-c-close-paren-_2A: ALTTO(c), figure 2A

ALTTO(c)_2AR Documentation

ALTTO(c), figure 2A

Description

Kaplan-Meier digitized data from ALTTO(c), figure 2A (PMID 26598744). A reported sample size of 8,381 for a primary endpoint of DFS in breast cancer.

Usage

`ALTTO(c)_2A`

Format

A data frame of 4,197 observations and 3 variables:

time event time (in years)
event DFS event indicator (0: no event, 1: event)
arm treatment arms (l, t)

Source

Piccart-Gebhart M, Holmes E, Baselga J, et al. Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial. J Clin Oncol 2016; 34: 1034–42.

Examples

summary(`ALTTO(c)_2A`)

kmplot(`ALTTO(c)_2A`)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.